Otolaryngology, Dipartimento delle Scienze Mediche, Chirurgiche e Sperimentali, Università di Sassari, Italy; Otolaryngology Division, Azienda Ospedaliero Universitaria, Sassari, Italy.
Fondazione Policlinico Universitario "A. Gemelli" IRCCS, UOC Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Roma, Italy.
Brachytherapy. 2021 Jan-Feb;20(1):178-184. doi: 10.1016/j.brachy.2020.08.008. Epub 2020 Oct 9.
Surgery, external beam radiotherapy (EBRT), and interventional radiotherapy (IRT, BrachyTherapy BT) are the current therapeutic options for nose vestibule (NV) squamous cell carcinoma (SCC). In this article, we evaluate the nose functional parameters of patients affected by SCCs of the NV, primarily treated by interstitial IRT comparing them with healthy controls and with patients treated with intensity-modulated EBRT.
Ten patients treated by using IRT (group 1), 10 healthy controls and eight patients treated by EBRT (group 2) on the region of the nose were submitted to clinical evaluation (with the NOSE scale score), rhinomanometry, olfactory testing, nasal citology, and evaluation of mucociliary clearance through saccharine test.
No long-term skin or cartilaginous toxicity are recorded. The olfactometry threshold discrimination identification TDI is lower in EB group. The mean NOSE scale score was significantly higher in group 2 than in group 1 and healthy controls (p < 0.05). The distribution of cytologic patterns resulted significantly different as well. Patients treated by EB have a significantly impaired mucociliary clearance, with a mean time for the transport of the stained marker, which is more than double in the patients treated by EB than in those treated with IRT (p < 0.001).
Nasal function and cytological findings are significantly better, substantially preserved, in patients treated by IRT than in those treated by EBRT, bringing new relevant evidence for the establishment of interstitial IRT as the new standard for the treatment of the primary lesion in cT1 and cT2 -Wang staging NV SCCs.
手术、外束放射治疗(EBRT)和介入放射治疗(IRT,近距离放射治疗 BT)是目前治疗鼻前庭(NV)鳞状细胞癌(SCC)的治疗选择。本文主要通过间质 IRT 治疗 NV SCC 患者,评估 NV SCC 患者的鼻部功能参数,并与健康对照组和接受调强 EBRT 治疗的患者进行比较。
10 例接受 IRT 治疗的患者(组 1)、10 例健康对照者和 8 例接受 EBRT 治疗的患者(组 2)纳入鼻腔区域的临床评估(NOSE 量表评分)、鼻阻力测量、嗅觉测试、鼻细胞学检查和糖精试验评估黏液纤毛清除率。
未记录到长期皮肤或软骨毒性。EB 组嗅觉计阈值辨别识别 TDI 较低。组 2 的平均 NOSE 量表评分明显高于组 1 和健康对照组(p < 0.05)。细胞学模式的分布也明显不同。EB 治疗组的黏液纤毛清除率明显受损,染色标记物的传输时间在 EB 治疗组患者中是 IRT 治疗组患者的两倍以上(p < 0.001)。
与接受 EBRT 治疗的患者相比,接受 IRT 治疗的患者的鼻部功能和细胞学发现明显更好,得到了实质性的保留,为将间质 IRT 确立为 cT1 和 cT2-Wang 分期 NV SCC 原发灶治疗的新标准提供了新的相关证据。